Adjuvant growth hormone therapy in antagonist protocol in poor responders undergoing assisted reproductive technology

M Eftekhar, A Aflatoonian, F Mohammadian… - Archives of gynecology …, 2013 - Springer
Purpose The incidence of poor ovarian response in controlled ovarian stimulation (COH)
has been reported in 9–24% of IVF-ET cycles. Growth hormone augments the effect of
gonadotropin on granulosa and theca cells, and plays an essential role in ovarian function,
including follicular development, estrogen synthesis and oocyte maturation. The aim of this
study was to assess IVF-ET cycle outcome after the addition of growth hormone in
antagonist protocol in poor responders. Materials and methods Eighty-two poor responder …

Adjuvant growth hormone therapy in antagonist protocol in poor responder.

M Eftekhar, F Mohammadian… - Iranian Journal of …, 2013 - search.ebscohost.com
Introduction: The incidence of poor ovarian response in controlled ovarian stimulation (COH)
has been reported in 9-24% of in vitro fertilization-embryo transfer (IVF-ET) cycles. Growth
hormone augments the effect of gonadotropin on granulosa and theca cells, and plays an
essential role in ovarian function, including follicular development, estrogen synthesis and
oocyte maturation. The aim of this study was to assess IVF-ET cycle outcome after the
addition of growth hormone in antagonist protocol in. Materials and Methods: Eighty-two …
以上显示的是最相近的搜索结果。 查看全部搜索结果